InflaRx Competitors and Similar CompaniesClear all
Grifols's competitors and similar companies include CorMedix.
 CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. | ||
Founding Date | Founding Date 1909 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Sant Cugat del Vallès, ES HQ Buenos Aires, AR Clayton South, AU São Paulo, BR Mississauga, CA Las Condes, CL see more | Locations Berkeley Heights, US HQ |
Employees | Employees 23,800 | Employees 3036% increase |
Valuation ($) | Valuation ($) 6.7 b | Valuation ($) 749.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) €7.5b (FY, 2025) | Revenue (est.) $311.7m (FY, 2025) |
Cost of goods | Cost of goods €4.2b (FY, 2025) | Cost of goods $22.1m (FY, 2025) |
Gross profit | Gross profit €3.3b (FY, 2025) | Gross profit $275.7m (FY, 2025) |
Net income | Net income €500m (FY, 2025) | Net income $163.1m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
CorMedix
HQ
Berkeley Heights, US
Employees
30↑ 36% increase
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
View company